Try our beta test site
1 study found for:    15737014 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET

Study has passed its completion date and status has not been verified in more than two years.